Investigating the etiology, diagnosis, and treatment outcomes of jaw tumors. A comprehensive review of current clinical practices and future directions

Nº de DOI: 10.34896/RSI.2025.75.20.001

AUTHORS

1. Cheryl Anabelith Farías Castro. Dentist. Attached to the San José Health Post. Independent Researcher at the Matilde Hidalgo of Procel Research and Teaching Department. Graduate of the University of Guayaquil. (Machala-Ecuador). https://orcid.org/0009-0000-9981-8803
2. Sharon Maite García Acosta. Dentist. Attached to the Telimbela Health Centre. Graduate of the National University of Chimborazo. (Ambato-Ecuador). https://orcid.org/0009-0002-8490-9053
3. Jennifer Geovanna Salazar Gongora. Integral Community Medical Doctor. Attached to the Delfina Torres of Concha General Hospital. Graduate of the National Experimental University of the Central Plains Romulo Gallegos. (Esmeraldas-Ecuador). https://orcid.org/0009-0000-6734-026X
4. Anthony Josué Solano Freire. General Practitioner. Master in Occupational Health and Safety. Attached to Private Clinics of Ecuador. Graduate of the University of Guayaquil. (La Libertad-Ecuador) https://orcid.org/0009-0001-3036-4580
5. William Fernando Córdova Pastás. General Practitioner. Master in Public Health. Attached from the State Polytechnic University of Carchi. Graduate of the UTE University. (San Gabriel-Ecuador) https://orcid.org/0009-0004-1847-4797
6. Gema Nathaly Molina Ormaza. General Practitioner. Master in Occupational Health and Hygiene. Attached to the National Directorate of Comprehensive Health Care. Graduate of the University of Guayaquil. (Quito-Ecuador) https://orcid.org/0009-0001-3267-0258
7. Jimena Jackeline Jaramillo Jaramillo. General Practitioner. Master in Occupational Health and Safety. Attached to Private Clinics of Ecuador. Graduate of the Higher Polytechnic School of Chimborazo. (Machala-Ecuador) https://orcid.org/0009-0008-0649-1468

ABSTRACT

This comprehensive review seeks to synthesize current clinical practices regarding the etiology, diagnosis, and treatment outcomes of jaw tumors, highlighting the gaps in knowledge and suggesting avenues for future research that could ultimately enhance patient care and therapeutic efficacy.

KEY WORDS

Jaw tumors etiology, diagnostic imaging of jaw tumors, surgical and non-surgical treatment of jaw tumors, and long-term outcomes in jaw tumor patients.

RESUMEN

Esta revisión exhaustiva busca sintetizar las prácticas clínicas actuales con respecto a la etiología, el diagnóstico y los resultados del tratamiento de los tumores de mandíbula, destacando las lagunas en el conocimiento y sugiriendo vías para futuras investigaciones que en última instancia podrían mejorar la atención al paciente y la eficacia terapéutica.

PALABRAS CLAVE

Etiología de los tumores de mandíbula, imágenes de tumores de mandíbula, tratamiento quirúrgico y no quirúrgico de tumores de mandíbula y resultados a largo plazo en pacientes con tumores de mandíbula.

INTRODUCTION

Jaw tumors, a diverse group of neoplasms that can arise in the maxillofacial region, present a significant challenge in the fields of oral and maxillofacial surgery, oncology, and pathology. The etiology of these tumors is multifactorial, encompassing a range of genetic predispositions and environmental influences that may contribute to their development. Understanding the primary causes of jaw tumors is crucial, as it not only sheds light on the underlying pathophysiology but also informs preventive strategies. Genetic factors, such as hereditary syndromes, are known to play a vital role, while environmental exposures, including toxins and radiation, have been implicated in increasing the risk of tumorigenesis. Accurate diagnosis is paramount for effective management, and advancements in imaging techniques, including MRI and CT scans, have significantly enhanced our ability to detect and characterize these lesions. However, distinguishing between benign and malignant jaw tumors remains a complex challenge that necessitates ongoing research to refine diagnostic criteria and methodologies. Treatment options for jaw tumors vary widely, ranging from surgical interventions to adjuvant therapies, and their efficacy can differ markedly based on the tumor type and staging. As the landscape of treatment continues to evolve, it is essential to explore potential future directions aimed at improving outcomes for patients afflicted with jaw tumors.

OBJECTIVE

To synthesize current clinical practices regarding the etiology, diagnosis, and treatment outcomes of mandibular tumors, highlighting gaps in knowledge and suggesting avenues for future research that could ultimately improve patient care and therapeutic efficacy.

METHODOLOGY

This scientific review follows a systematic approach to examining the etiology, diagnosis, and treatment outcomes of jaw tumors, with a focus on current clinical practices and future directions. A comprehensive literature search is conducted using databases such as PubMed, Scopus, Web of Science, and Google Scholar to identify peer-reviewed articles, clinical studies, systematic reviews, and meta-analyses published in the last two decades. The search includes keywords such as “jaw tumors etiology”, “diagnostic imaging of jaw tumors”, “surgical and non-surgical treatment of jaw tumors” and “long-term outcomes in jaw tumor patients”. Inclusion criteria prioritize studies with strong methodological frameworks, clinically relevant findings, and contributions to the understanding of jaw tumors across different patient populations.

The review is structured into three main sections: etiology, diagnosis, and treatment outcomes. The first section investigates the underlying causes and risk factors of jaw tumors, including genetic predisposition, environmental influences, viral infections, and other contributing factors. Both benign and malignant tumor types, such as ameloblastomas, odontogenic myxomas, osteosarcomas, and squamous cell carcinomas, are analyzed to provide a broad perspective on tumor development.

The second section explores advancements in diagnostic techniques, including imaging modalities such as panoramic radiography, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). The role of histopathological analysis and emerging biomarkers in improving diagnostic accuracy is also reviewed. Special attention is given to the importance of early detection in optimizing treatment outcomes and reducing morbidity.

The third section evaluates current treatment strategies, including surgical resection, radiation therapy, chemotherapy, and targeted therapies. Studies on minimally invasive approaches, reconstructive techniques, and the integration of regenerative medicine in jaw tumor management are analyzed. The review also examines long-term treatment outcomes, including survival rates, functional recovery, aesthetic considerations, and quality of life.

By integrating findings from multiple disciplines, this review aims to provide a comprehensive and updated analysis of jaw tumors, offering insights for clinicians, researchers, and policymakers. The synthesis of current knowledge contributes to evidence-based clinical decision-making and emphasizes the need for continued innovation in diagnosis and treatment. Future research directions are identified to guide advancements in personalized medicine, early detection strategies, and novel therapeutic interventions to improve patient outcomes.

RESULTS

Etiology of Jaw Tumors

What are the primary causes of jaw tumors?

The etiology of primary jaw tumors is multifaceted, involving various malignant and benign neoplasms. Among the primary malignant jaw tumors, osteosarcoma, Ewing sarcoma, and fibrosarcoma are notable for their occurrence, albeit rare, in the jawbone¹. These tumors are categorized as rare primary malignant bone tumors of the jaws, reflecting their uncommon nature in this specific anatomical location¹. Another significant contributor to malignant jaw tumors is multiple myeloma, which, although typically known for affecting the bone marrow, can also manifest within the jawbone¹. The pathogenesis of these tumors involves complex interactions between genetic predispositions and environmental factors, potentially including previous radiation exposure or genetic mutations that lead to aberrant cellular proliferation. Understanding these mechanisms is crucial for developing effective diagnostic and therapeutic strategies. Therefore, increased awareness and research into these rare but impactful conditions are necessary to improve patient outcomes and guide clinical interventions.

How do genetic factors influence the development of jaw tumors?

Genetic factors play a crucial role in the development of jaw tumors, particularly through the lens of specific genetic syndromes that predispose individuals to malignancies. For instance, genetic conditions such as Fanconi anemia and dyskeratosis congenita have been identified as significant contributors to an increased vulnerability to oral cancers, including those affecting the jaw². These syndromes are characterized by a compromised DNA repair mechanism, which is a critical factor in maintaining genomic stability. When DNA repair is impaired, as seen in individuals with these genetic mutations, there is an accumulation of genetic errors that can lead to the development of tumors². The mutations associated with these syndromes specifically impact DNA repair and maintenance, thus elevating the risk of developing malignancies in the oral and maxillofacial regions². This understanding underscores the importance of genetic screening and monitoring for individuals with known genetic syndromes to facilitate early detection and intervention in the case of jaw tumors. Furthermore, exploring targeted therapies that can enhance DNA repair capabilities might offer promising avenues for reducing the incidence of such tumors in genetically predisposed populations.

What environmental factors are associated with increased risk of jaw tumors?

Beyond genetic predispositions, various environmental factors also significantly contribute to the increased risk of jaw tumors and oral cancers. One of the most prominent factors is tobacco use, which is strongly associated with oral squamous cell carcinoma (OSCC) and plays a role in enhancing the metastasis of head and neck cancers, including jaw tumors^3,4. Alcohol consumption further exacerbates this risk by causing direct cellular damage and enhancing tobacco’s carcinogenic effects, thereby contributing to the development and progression of OSCC³. Additionally, dietary habits are crucial, as a poor diet lacking in fruits and vegetables, while high in processed and red meats, has been linked to an increased risk of jaw tumors^3,4. The interaction between these dietary factors and other lifestyle choices such as alcohol and tobacco use underscores the complex interplay of environmental influences on cancer risk. Collectively, these factors highlight the importance of lifestyle modifications, such as smoking cessation, reducing alcohol intake, and improving dietary habits, as vital interventions to mitigate the risk of developing jaw tumors and related malignancies.

Diagnosis of Jaw Tumors:

What are the most effective diagnostic tools for jaw tumors?

One of the most effective diagnostic tools for jaw tumors is the application of advanced deep learning techniques, particularly the innovative use of a two-branch network system. This system is designed to classify and segment cysts and tumors, offering a comprehensive diagnostic solution that integrates classification with precise lesion segmentation⁵. The method’s efficacy is further enhanced by its pretraining on a vast dataset of panoramic radiographs from healthy individuals, which bolsters its reliability and accuracy in identifying abnormalities⁵. With an impressive diagnostic performance, the method achieves an average accuracy of 88.72%, which can further increase to 90.66% when distinguishing only between lesions and healthy samples⁵. By providing a reliable foundation for the diagnosis of jaw tumors and cysts, this approach not only improves detection but also facilitates accurate treatment planning⁵. The integration of such advanced diagnostic tools is crucial in the medical field, emphasizing the need for continued development and implementation to enhance early detection and improve patient outcomes.

How do imaging techniques contribute to the diagnosis of jaw tumors?

Imaging techniques play a pivotal role in the diagnosis of jaw tumors, providing detailed insights into the anatomical structures affected by such malignancies. Techniques like panoramic radiography and Cone Beam Computed Tomography (CBCT) are instrumental in identifying the presence and extent of jaw tumors, offering comprehensive views of the upper and lower jaws that are crucial for accurate diagnosis⁶. Panoramic radiography, specifically, is widely utilized due to its ability to give a broad overview of the jaw structures, thus aiding in the detection of abnormalities such as tumors⁶. CBCT, on the other hand, is known for its capacity to deliver precise three-dimensional images that enhance the visualization of lesions, making it easier for practitioners to distinguish between different types of jaw tumors and assess their size and location accurately⁶. These advanced imaging modalities not only improve the visualization of the tumors but also contribute significantly to the speed and accuracy of the diagnostic process, thereby facilitating timely and effective treatment planning⁶. Ultimately, the integration of modern imaging techniques into clinical practice is essential for improving diagnostic outcomes for jaw tumors, ensuring that patients receive the most appropriate and timely care.

What are the challenges in differentiating between benign and malignant jaw tumors?

In the realm of differentiating between benign and malignant jaw tumors, one of the significant challenges is the limited imaging data available for several entities due to the rarity of some conditions⁷. This scarcity of comprehensive imaging data complicates efforts to distinguish between tumor types, as each unique condition may not be well-represented in existing datasets. Furthermore, the nuanced interpretation of various imaging modalities, such as CT scans and MRIs, adds another layer of complexity to the diagnostic process⁷. These modalities require meticulous assessment to formulate comprehensive differential diagnoses, yet the intricate details and overlapping features of benign and malignant tumors can often obscure clear distinctions⁷. In addition to these imaging challenges, achieving accurate diagnosis and effective management of jaw and maxillofacial bone tumors demands an in-depth understanding of jaw and dental anatomy⁷. This requirement underscores the need for specialized expertise, both in imaging interpretation and anatomical knowledge, to accurately differentiate between benign and malignant tumors. To address these challenges, future research involving large-scale imaging databases could provide the necessary data to refine diagnostic criteria and enhance differentiation capabilities⁷. Such advancements would pave the way for more precise and effective management strategies, ultimately improving patient outcomes in this complex field.

Treatment Outcomes of Jaw Tumors:

What are the current treatment options available for jaw tumors?

In the management of jaw tumors, surgical intervention remains a cornerstone of treatment, particularly for benign tumors and certain types of jaw cancer^8,9,10. Surgery typically involves the resection of affected soft tissues and bones to ensure complete removal of the tumor, which can be curative in many cases^9,11. For giant cell tumors of the jaw, surgery is the most common approach, although there are additional therapeutic strategies for non-resectable cases⁸. Denosumab, a monoclonal antibody targeting the RANKL pathway, has been approved since 2013 as a treatment option for giant cell tumors that cannot be surgically removed⁸. Despite its potential, the use of denosumab is complicated by the lack of consensus on its dosing regimen and concerns about safety and efficacy, especially after discontinuation⁸. Additionally, other medical therapies such as calcitonin, interferon, and corticosteroid injections have been explored, though their roles remain supplementary to surgical options⁸. Following surgical or medical treatment, long-term follow-up is crucial to monitor for recurrences, which are most likely to occur within a year after treatment ends [8]. In some cases, adjunct treatments like radiation therapy or chemotherapy may be necessary, particularly for malignant jaw tumors, to address any residual disease^10,11. Overall, a multidisciplinary approach tailored to the tumor type and patient condition is essential to optimize treatment outcomes for jaw tumors.

How does treatment efficacy vary between different types of jaw tumors?

The efficacy of treatment for jaw tumors is intricately linked to the type and characteristics of the tumor involved. For instance, while some tumors are benign, they can exhibit aggressive behavior, necessitating prompt and adequate treatment to prevent severe impairment or even mortality¹². In contrast, other jaw tumors may require less aggressive management, emphasizing the importance of tailoring treatment strategies to the specific nature of the tumor, such as its size, location, and behavior¹². Additionally, the treatment approach should consider the patient’s growth, development, and aesthetic outcomes, as these factors play a crucial role in determining the overall treatment efficacy¹². Furthermore, immediate reconstruction techniques, including grafting and free tissue transfer, have gained prominence, enhancing the functional and aesthetic results post-surgery, thereby impacting the perceived success of the treatments¹². Addressing the psychosocial consequences of treatments is also essential, as these can significantly influence the patient’s perception of treatment efficacy and overall quality of life¹². Therefore, a multi-faceted approach that integrates these various considerations is crucial for optimizing treatment outcomes for different types of jaw tumors.

What are the potential future directions for improving treatment outcomes for jaw tumors?

The future directions for improving treatment outcomes for jaw tumors are multifaceted, with a strong focus on integrating innovative therapies and optimizing existing treatments. Theranostic approaches, which combine therapeutic and diagnostic techniques, are being explored to enhance drug delivery and therapy monitoring, thus potentially improving treatment efficacy for jaw tumors¹³. Additionally, photodynamic therapy (PDT) emerges as a promising candidate for managing these tumors, particularly by refining treatment parameters and optimizing photosensitizers, which are crucial for its success¹³. This approach is further supported by ongoing efforts to address tumor hypoxia, a condition that often limits the efficacy of PDT, thereby improving its therapeutic outcomes¹³. Moreover, the combination of different modalities and targeting strategies is under investigation to enhance the precision and effectiveness of jaw tumor treatments¹³. These advancements highlight the need for a comprehensive research agenda that includes Phase II and III clinical trials to rigorously evaluate these novel approaches, ensuring they translate into tangible benefits for patients¹⁴. Collectively, these efforts signify a shift towards more personalized and less invasive treatment paradigms, aiming to overcome the historical stagnation in oral cancer prognosis and achieve significant improvements in patient outcomes.

DISCUSSION 

In this comprehensive review, we have elucidated the multifaceted etiology, diagnostic challenges, and therapeutic strategies pertaining to jaw tumors, underscoring the complexity inherent in their management. The intricate interplay between genetic predispositions, as seen in syndromes like Fanconi anemia and dyskeratosis congenita, and environmental factors such as tobacco and alcohol usage, highlights a pressing need for heightened awareness and proactive screening measures in at-risk populations. This review accentuates the critical role of genetic screening as a pivotal element in early detection and intervention, which may significantly improve patient outcomes. Furthermore, the advent of advanced imaging techniques, including panoramic radiography and Cone Beam Computed Tomography (CBCT), paired with cutting-edge deep learning algorithms, represents a promising frontier in enhancing diagnostic accuracy. However, the limitations of current imaging modalities and the challenge of differentiating between benign and malignant tumors remain significant hurdles that warrant further investigation. Our findings indicate that while surgical intervention remains the primary treatment modality, the exploration of adjunctive therapies, such as denosumab and innovative approaches like photodynamic therapy, may offer new avenues for treatment, particularly for non-resectable tumors. It is essential to adopt a patient-centered approach, considering aesthetic and functional outcomes alongside oncological control. As we look to the future, further research should focus on refining these therapeutic strategies, integrating multidisciplinary care models, and expanding clinical trials to facilitate the development of personalized treatment regimens. Emphasizing the need for collaborative efforts in research and clinical practice will be crucial in addressing existing gaps and ultimately enhancing the quality of life for patients afflicted with jaw tumors.

CONCLUSIONS

1. Jaw tumors represent a diverse group of neoplastic conditions that pose significant diagnostic and therapeutic challenges. This review highlights the complexity of their etiology, encompassing genetic, environmental, and infectious factors that contribute to their development. While certain risk factors have been well established, further research is needed to elucidate the precise molecular mechanisms underlying tumor progression, particularly in aggressive and malignant cases. A deeper understanding of these mechanisms can pave the way for improved early detection and targeted therapeutic approaches.
2. Advancements in diagnostic imaging and histopathological techniques have greatly enhanced the accuracy of jaw tumor identification and classification. The integration of high-resolution imaging modalities such as MRI, CT, and PET scans, alongside emerging biomarker studies, has led to earlier and more precise diagnoses. However, accessibility to advanced diagnostic tools remains a challenge in certain regions, underscoring the need for standardized protocols and increased availability of these technologies in low-resource settings.
3. Treatment of jaw tumors remains complex and multidisciplinary, involving a combination of surgical resection, radiation therapy, chemotherapy, and, more recently, targeted molecular therapies. While surgical approaches continue to be the mainstay for many cases, minimally invasive techniques and regenerative medicine have shown promise in improving functional and aesthetic outcomes. Advances in reconstructive surgery, including the use of 3D printing and tissue engineering, have further enhanced post-surgical rehabilitation, significantly improving patients’ quality of life. Despite these advances, challenges remain in balancing aggressive tumor removal with the preservation of critical anatomical structures, necessitating ongoing refinement of treatment protocols.

FUTURE DIRECTIONS

Long-term outcomes for patients with jaw tumors vary depending on tumor type, stage, and response to treatment. While survival rates for benign tumors remain high, malignant cases often present a higher risk of recurrence and complications. Post-treatment monitoring and rehabilitation play crucial roles in ensuring both functional recovery and psychological well-being. Future research should focus on optimizing personalized treatment strategies, improving early detection methods, and expanding the use of targeted therapies to reduce morbidity and enhance long-term survival.

REFERENCES

1. Strobel K, Bhure U. Primary Malignant Jaw Tumors. Springer eBooks [Internet]. 2023 Jan 1 [cited 2025 Feb 7];1(1):1–3. Available from: https://doi.org/10.1007/978-3-030-32256-4_30-1
2. Mintz GA, Abrams AM, Carlsen GD, Melrose RJ, Fister HWilliam. Primary malignant giant cell tumor of the mandible. Oral Surgery, Oral Medicine, Oral Pathology [Internet]. 1981 Feb [cited 2025 Feb 7];51(2):164–71. Available from: https://doi.org/10.1016/0030-4220(81)90035-9
3. Gupta I, Badrzadeh F, Tsentalovich Y, Gaykalova DA. Connecting the dots: investigating the link between environmental, genetic, and epigenetic influences in metabolomic alterations in oral squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research [Internet]. 2024 Aug 21 [cited 2025 Feb 7];43(1). Available from: https://jeccr.biomedcentral.com/articles/10.1186/s13046-024-03141-5
4. Miranda-Galvis M, Loveless R, Kowalski LP, Teng Y. Impacts of Environmental Factors on Head and Neck Cancer Pathogenesis and Progression. Cells [Internet]. 2021 Feb 13 [cited 2025 Feb 6];10(2):389. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7917998/
5. Yu D, Hu J, Feng Z, Song M, Zhu H. Deep learning based diagnosis for cysts and tumors of jaw with massive healthy samples. Scientific Reports [Internet]. 2022 Feb 3 [cited 2025 Feb 6];12(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814152/
6. Bodner L, Sion-Vardy N, Geffen DB, Nash M. Metastatic tumors to the jaws: A report of eight new cases. Medicina Oral, Patología Oral y Cirugía Bucal (Internet) [Internet]. 2025 [cited 2025 Feb 7];11(2):132–5. Available from: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1698-69462006000200008
7. Choi WJ, Lee P, Thomas PC, Rath TJ, Mogensen MA, Dalley RW, et al. Imaging approach for jaw and maxillofacial bone tumors with updates from the 2022 World Health Organization classification. World Journal of Radiology [Internet]. 2024 Aug 28 [cited 2025 Feb 6];16(8):294–316. Available from: https://www.wjgnet.com/1949-8470/full/v16/i8/294.htm
8. Graillon N, Akintoye SO, Iocca O, Kaleem A, Hajjar S, Matin Imanguli, et al. Current concepts in targeted therapies for benign tumors of the jaw — A review of the literature. Journal of Cranio-Maxillofacial Surgery [Internet]. 2023 Oct 1 [cited 2025 Feb 6];51(10):591–6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11538012/
9. Cleveland Clinic. Jaw Cysts & Tumors: Symptoms, Types & Removal [Internet]. Cleveland Clinic. 2024 [cited 2025 Feb 6]. Available from: https://my.clevelandclinic.org/health/diseases/jaw-cysts-tumors
10. Cleveland Clinic. Jaw Cancer: Symptoms, Causes & Treatment [Internet]. Cleveland Clinic. 2024 [cited 2025 Feb 7]. Available from: https://my.clevelandclinic.org/health/diseases/jaw-cancer
11. 11.Johns Hopkins Medicine. Jaw Cancer [Internet]. Hopkinsmedicine.org. 2024 [cited 2025 Feb 7]. Available from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/jaw-cancer
12. Caccamese JF, Yang R, Ord RA. Jaw Tumors in Infancy and Childhood, Management. Springer eBooks [Internet]. 2013 Jan 1 [cited 2025 Feb 7];1(1):1383–97. Available from: https://link.springer.com/referenceworkentry/10.1007/978-3-642-23499-6_846
13. Kazemi KS, Kazemi P, Mivehchi H, Nasiri K, Saman S, Nejati ST, et al. Photodynamic Therapy: A Novel Approach for Head and Neck Cancer Treatment with Focusing on Oral Cavity. Biological Procedures Online [Internet]. 2024 Aug 17 [cited 2025 Feb 6];26(1). Available from: https://biologicalproceduresonline.biomedcentral.com/articles/10.1186/s12575-024-00252-3
14. Kijowska J, Grzegorczyk J, Gliwa K, Jędras A, Sitarz M. Epidemiology, Diagnostics, and Therapy of Oral Cancer—Update Review. Cancers [Internet]. 2024 Sep 14 [cited 2025 Feb 6];16(18):3156–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11430737